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protocol for an open pilot study and external
pilot clustered randomised controlled trial to
assess acceptability, feasibility and fidelity of a
multifaceted behavioural intervention targeting
physical activity in primary care
Leah Avery1,2*, Falko F Sniehotta2,3, Sarah J Denton1, Nick Steen3, Elaine McColl4, Roy Taylor5 and Michael I Trenell1Abstract
Background: Physical activity (PA) and nutrition are the cornerstones of diabetes management. Several reviews
and meta-analyses report that PA independently produces clinically important improvements in glucose control in
people with Type 2 diabetes. However, it remains unclear what the optimal strategies are to increase PA behaviour
in people with Type 2 diabetes in routine primary care.
Methods: This study will determine whether an evidence-informed multifaceted behaviour change intervention
(Movement as Medicine for Type 2 Diabetes) targeting both consultation behaviour of primary healthcare
professionals and PA behaviour in adults with Type 2 diabetes is both acceptable and feasible in the primary
care setting. An open pilot study conducted in two primary care practices (phase one) will assess acceptability,
feasibility and fidelity. Ongoing feedback from participating primary healthcare professionals and patients will provide
opportunities for systematic adaptation and refinement of the intervention and study procedures. A two-arm parallel
group clustered pilot randomised controlled trial with patients from participating primary care practices in North East
England will assess acceptability, feasibility, and fidelity of the intervention (versus usual clinical care) and trial processes
over a 12-month period. Consultation behaviour involving fidelity of intervention delivery, diabetes and PA related
knowledge, attitudes/beliefs, intentions and self-efficacy for delivering a behaviour change intervention targeting PA
behaviour will be assessed in primary healthcare professionals. We will rehearse the collection of outcome data (with
the focus on data yield and quality) for a future definitive trial, through outcome assessment at baseline, one, six and
twelve months. An embedded qualitative process evaluation and treatment fidelity assessment will explore issues
around intervention implementation and assess whether intervention components can be reliably and faithfully
delivered in routine primary care.
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Discussion: Movement as Medicine for Type 2 Diabetes will address an important gap in the evidence-base, that
is, the need for interventions to increase free-living PA behaviour in adults with Type 2 diabetes. The multifaceted
intervention incorporates an online accredited training programme for primary healthcare professionals and represents, to
the best of our knowledge, the first of its kind in the United Kingdom. This study will establish whether the multifaceted
behavioural intervention is acceptable and feasible in routine primary care.
Trial registration: Movement as Medicine for Type 2 Diabetes (MaMT2D) was registered with Current Controlled Trials
on the 14th January 2012: ISRCTN67997502. The first primary care practice was randomised on the 5th October 2012.
Keywords: Open pilot, Randomised controlled trial, Behaviour change, Type 2 diabetes, Physical activity, Exercise, Fidelity,
Primary careBackground
It is estimated that 171 million people worldwide in the
year 2000 had a diagnosis of Type 2 diabetes, which is
predicted to rise to 366 million by 2030 [1]. Factors con-
tributing to the increased prevalence of Type 2 diabetes
include increased or unchanged calorie consumption
combined with limited energy expenditure [2]. Reduced
energy expenditure is important because the majority of
people with Type 2 diabetes, or those at highest risk for
developing the condition, are physically inactive com-
pared with national norms [3].
Physical activity (PA)/exercise is widely considered
to be an integral element of diabetes management
[4]. Several reviews [5,6] and meta-analyses [4,7-9] of
laboratory-based studies demonstrate that PA/exercise
can produce a clinically important improvement in glu-
cose control in people with Type 2 diabetes (in the ab-
sence of weight loss) producing an average improvement
in glycated hemoglobin A1c (HbA1c) of between −0.4%
and −0.6%. While this improvement is comparable to
pharmacological therapies [10], pharmacology does not
provide a long-term solution to glucose control in this
largely progressive condition. Appropriate lifestyle be-
haviour changes, such as increased engagement in free-
living PA, are therefore required to halt progression to
subsequent classifications of drugs or insulin therapy. A
2012 meta-analysis of randomised controlled trials
(RCTs) of behavioural interventions targeting free-living
PA/exercise in adults with Type 2 diabetes found a clin-
ically important improvement in HbAlc of −0.32%, (95%
confidence interval (CI) = −0.44% to −0.21%) demon-
strating that outcomes observed under laboratory condi-
tions can be replicated in clinical and community
settings when using evidence-based behavioural strat-
egies [11].
The Department of Health for England currently rec-
ommends that adult’s ≥19 years old should accumulate a
minimum of 150 minutes of moderate intensity PA each
week to achieve tangible health benefits [12]. However,
despite the known benefits of PA, there remains a short-
age of effective interventions that can be offered in theprimary care setting to adults with Type 2 diabetes to
support them to increase their levels of PA [13]. With
traditional advice-giving approaches being largely inef-
fective, behavioural interventions that aim to increase
PA/exercise and maximise glycaemic control in the
long-term are needed. Furthermore, targeting PA in the
primary care setting is particularly promising because
people with Type 2 diabetes have regular contact with
their primary care team; therefore, multiple opportun-
ities exist for delivery of effective interventions by pri-
mary healthcare professionals.
Although national guidelines outline the need for pa-
tient education models in the management of Type 2
diabetes [14] evidence-based tools are lacking. This is es-
pecially the case with respect to advice on effective strat-
egies/techniques for use by diabetes care providers to
increase levels of PA/exercise. The majority of people
with Type 2 diabetes in the UK are offered some form of
education/intervention, at least at the point of diagnosis;
however, the length, information content and style of the
interventions vary greatly between services. The majority
of interventions do not include adequate support to help
people with Type 2 diabetes to achieve PA recommenda-
tions, very few have been formally evaluated, and rarely
have the individuals responsible for the delivery of these
interventions been formally trained for this purpose
[15]. A 2012 systematic review of behavioural interven-
tions targeting PA/exercise reported that five out of
seventeen RCTs targeting PA/exercise referred to train-
ing for care providers. Furthermore, two of these five tri-
als explicitly described the content of training provided,
and none of the included trials attempted to assess the
efficacy of the training on consultation behaviour [11].
With so few primary studies explicitly utilising treatment
fidelity strategies to monitor and improve training for
care providers (where training is offered), or to monitor
the delivery of interventions to patients in practice, it is
difficult to establish whether the interventions are being
delivered as intended. Therefore it becomes impossible
to decipher whether reported outcomes are a function of
the intervention or ‘non-intervention’ factors [16].
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The multifaceted behaviour change intervention ‘Move-
ment as Medicine for Type 2 Diabetes’ (MaMT2D) aims to
address the evidence gaps outlined above. The first compo-
nent is an online training intervention programme for pri-
mary healthcare professionals to develop knowledge and
skills for (1) use of a range of behaviour change counselling
skills and evidence-based behaviour change techniques for
improving free-living PA behaviour; and (2) delivery of a
primary healthcare professional-led intervention to engage
adults with Type 2 diabetes in discussions about increasing
their levels of free-living PA. The second component (pri-
mary healthcare professional-led intervention) provides
adults with Type 2 diabetes with evidence based interven-
tion strategies and a range of resources to facilitate an in-
crease in free-living PA behaviour; for example decisional
balance aids, activity planners/trackers and pedometers
(SW200, Yamax Corporation, Tokyo, Japan).
Following the Medical Research Council framework for
the development and evaluation of complex interventions
[17,18], the current intervention was developed following
an initial needs assessment with patients and primary
healthcare professionals. This informed a subsequent par-
ticipatory development process involving primary health-
care professionals, psychologists, physiologists, clinical
experts, designers and adults with Type 2 diabetes in the
primary care setting. This allowed identification of the
most appropriate mode of delivery and form of interven-
tion components for patients and primary healthcare
professionals.
The information content of MaMT2D was informed
by the findings of a systematic review and meta-analysis
of behavioural interventions targeting free-living PA/ex-
ercise in adults with Type 2 diabetes [11]. This review
reported on a series of moderator analyses to identify
specific candidate behaviour change techniques and
intervention features associated with clinical effective-
ness (≥0.3% reduction in HbA1c). Moderator analyses
showed positive associations between theory-based inter-
ventions and clinical effectiveness (although no one the-
ory held benefit over another), including interventions
lasting at least six months in duration and interventions
that utilised ≥10 behaviour change techniques. Analyses
did not identify a specific mode of delivery (group ses-
sions versus individual face-to-face sessions versus a
combination of group and individual face-to-face ses-
sions) associated with clinical effectiveness; therefore,
mode of delivery was selected in accordance with the
views elicited from primary healthcare professionals (on-
line) and patients (individual face-to-face sessions) dur-
ing the participatory development process.
Given that the optimal theoretical underpinning of be-
haviour change interventions targeting PA in the context
of diabetes care was not elucidated by the systematicreview, key selection criteria were agreed for theory se-
lection. These criteria included a strong evidence-base
for modelling the process of intervention components
and outcomes that were the foci of MaMT2D (increas-
ing free-living PA in adults with type 2 diabetes and en-
hancing consultation behaviour of primary healthcare
professionals to deliver a PA behavioural intervention to
adults with type 2 diabetes).
Exploratory work with primary healthcare profes-
sionals and patients identified the need to target: 1) mo-
tivational factors, such as attitudes/beliefs regarding the
use of PA by healthcare professionals as a management
option for people with Type 2 diabetes; 2) volitional fac-
tors, such as self-efficacy to increase and maintain in-
creases in PA behaviour in adults with Type 2 diabetes;
and 3) self-efficacy of healthcare professionals for deliv-
ering a behavioural intervention in routine primary care.
Therefore, additional criteria for guiding theory selection
included: 1) capable of targeting both motivational and
volitional factors [19]; and 2) existence of in-built con-
structs and evidence-based strategies that can be used
effectively to target both motivation/intention and actual
behaviour to support maintenance. Furthermore, theor-
ies needed to have readily available, reliable and valid in-
struments to measure the theoretical constructs and
postulated relationships between constructs to inform
the evaluation strategy for MaM2TD.
In accordance with these explicit criteria, the Theory of
Planned Behaviour (TPB) [20] and Social Cognitive The-
ory (SCT) [21] were selected to underpin the development
and evaluation of the MaMT2D intervention. The TPB
has been extensively and successfully used to predict in-
tentions to increase PA and actual PA behaviour [22] in-
cluding healthcare professional behaviour change [23].
However, the TPB does not provide guidance on how the-
oretical constructs can be targeted within interventions
using evidence-based strategies, or how to address the fre-
quent lack of concordance between motivation/intention
and action, that is the ‘intention-behaviour’ gap [24].
SCT has demonstrated utility in samples of people
with diabetes when predicting PA behaviour [25] and
provides specific evidence-based strategies for translat-
ing motivation/intentions into action/behaviour in both
healthcare professionals and patients (for example, obser-
vational learning strategies, such as modelling to support
the acquisition of behaviour changes skills and self-
efficacy for the effective delivery of behaviour change tech-
niques to patients). Together the TPB and SCT provide a
complimentary theoretical framework for guiding the de-
sign and evaluation of the intervention components within
MaMT2D.
In addition, a 2012 systematic review and meta-analysis
identified a range of evidence-based behaviour change tech-
niques associated with clinically important improvements
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These techniques were included in the MaM2TD interven-
tion alongside other evidence-based intervention compo-
nents/techniques informed by TPB and SCT. Briefly they
are: use of follow-up prompts (PA behaviour will be
prompted at the three-month time point via a telephone
call from a participating primary healthcare professional
and a motivational postcard from the research team); infor-
mation on where and when to perform PA behaviour (pri-
mary healthcare professionals will be given access to an
online repository where they can access specific details
about local activities, for example, time and location); plan
social support/social change (patients will be encouraged to
elicit support (practical or emotional) from friends and
family members); goal setting behaviour (patients will be
supported to set their own PA goals); barrier identification/
problem solving (patients will be asked to consider in ad-
vance barriers to attaining their goals and encouraged to
consider ways to overcome them); time management (pa-
tients will be supported to identify appropriate times to be
active); prompt rewards contingent on effort or progress
made towards a predetermined goal (patients will be en-
couraged to reward any progress made towards PA goals);
prompt review of behavioural goals (PA goals will be
reviewed four times over a twelve-month period); prompt
generalisation of PA behaviour (patients will be supported
to increase PA behaviour in a different setting or situation
once they have mastered it in one setting); prompt focus
on past success (patients will be asked to consider past suc-
cessful attempts at PA); provide information on the conse-
quences of behaviour to the individual (patients will receive
specific and relevant information if/when requested, for ex-
ample, the effect of PA on their HbA1c); feedback on per-
formance (feedback on consequences of behaviour will be
provided to patients during each review appointment); ac-
tion planning (patients will be supported to set SMART
goals (specific, measurable, achievable, realistic and timely)
[26]; and self-monitoring of PA behaviour (patients will be
offered use of activity planners, trackers and a pedometer).
The efficacy of several techniques identified by the sys-
tematic review (and others included in the current inter-
vention) has been reported previously in the context of
PA behaviour change. For example, interventions utilis-
ing action planning and coping planning were found to
predict an increase in PA [27]. Indeed, it has been re-
ported that inclusion of both action planning and
coping planning at different stages of the behaviour
change process is optimal when targeting PA behaviour
change [28,29]. Self-regulation strategies, such as self-
monitoring, are reported to be more effective than inter-
ventions not utilising this technique [30,31]. Further-
more, the effectiveness of interventions is optimised
when self-monitoring is combined with at least one
other self-regulatory technique [32].The behaviour change techniques selected are consistent
with theories used to integrate and organise the delivery of
techniques in MaMT2D [33]. The online training interven-
tion programme is designed to provide primary healthcare
professionals with the knowledge, skills and confidence
(self-efficacy) to use the MaMT2D behaviour change tech-
niques and intervention components in practice.
Finally, primary healthcare professionals will be shown
how to use a range of behaviour change strategies/counsel-
ling skills to promote PA behaviour change. These include:
agenda setting; use of importance and confidence rulers to
initiate change talk; a decisional balance aid to discuss pros
and cons for change; and communication skills (asking
open questions, active listening and informing).
This protocol describes a two-phase process that will be
used to develop and evaluate MaMT2D. Phase one is an
open pilot study that will assess the acceptability, feasibility
and fidelity of delivery of MaMT2D and will provide oppor-
tunities for intervention optimisation and refinement of
study processes and procedures. Phase two is an external
pilot cluster randomised controlled trial (RCT) that will as-
sess acceptability, feasibility, and fidelity of MaMT2D (in-
formed by any necessary optimisation identified in phase
one) over a 12 month period. A qualitative process evalu-
ation and treatment fidelity assessment will be carried out
throughout the trial period, to identify any barriers and fa-
cilitators to implementation as well as adherence to the
study protocol by primary healthcare professionals and pa-
tients. The pilot RCT will be conducted and reported in ac-
cordance with the Consolidated Standards of Reporting
Trials (CONSORT) [34] and the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT) guide-
lines [See Additional file 1: SPIRIT Checklist) [35].
Phase One: Movement as Medicine for Type 2 Diabetes:
Open Pilot Study
Objectives
The primary objective is to conduct an open pilot study
to establish the acceptability, feasibility and fidelity of
the multifaceted intervention MaMT2D in the primary
care setting. Intervention components will be iteratively
optimised incorporating feedback from primary health-
care professionals and patients during the open pilot
study. Recruitment, retention and adherence rates, in-
cluding willingness to take part in video recordings of
consultations, semi structured interviews, focus group
discussions and complete study outcome measures will
be assessed to inform a pilot RCT (phase two).
Methods/design
The open pilot study (phase one) will assess and opti-
mise the acceptability, feasibility and fidelity of interven-
tion delivery before MaMT2D enters a pilot RCT.
Due to the high level of user involvement (healthcare
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velopment process, it is unlikely that the open pilot study
will raise any important issues. An open pilot component
was incorporated to identify and resolve any implementation
issues and facilitate refinements to the intervention ahead of
a planned pilot RCT. This will increase the likelihood that
the intervention will be acceptable, feasible and delivered to
a satisfactory level of fidelity. Should the open pilot indicate
that some modifications to the intervention and research
procedures are needed, these will be made prior to moving
onto the pilot RCT.
Sample size
Two primary care practices in the County Durham and
Darlington area of North East England will each recruit
15 patients (n = 30) in line with standard guidance for
pilot studies [36].
Eligibility criteria for primary care practices
The eligibility criteria for primary care practices are as
follows:
1. Willingness to be randomised to the intervention or
control group.
2. A commitment to participate over the duration of
the study (12-months).
3. Allow participation of at least two primary
healthcare professionals in the study.
4. Capacity and willingness to identify and recruit
patients meeting the eligibility criteria.
5. Allow access to patient records for collection of
clinical data.
6. Willingness to complete the study as per the protocol.
Participating primary healthcare professionals will be all
members of the primary care team. These include general
practitioners, practice nurses, nurse practitioners, health-
care assistants, and allied health professionals (for ex-
ample, physiotherapists and occupational therapists).
Primary healthcare professionals will be excluded from the
study if they are currently taking part in any behaviour
change intervention research.
Eligibility criteria for patients
The eligibility criteria for patients are as follows:
1. Aged 18 years and older.
2. A confirmed diagnosis of non-insulin dependent
Type 2 diabetes for a minimum of two years.
3. Capacity to provide informed written consent (that
is, as established by the primary healthcare
professional responsible for the patient’s care).
4. Ability to write and converse in English (that is, patients
who do not require the support of an interpreter).Patients will be excluded if they are currently taking part
in any other intervention research studies; are prescribed
sulphonylureas; or have evidence of heart disease, musculo-
skeletal disorders or other disabling conditions that could
be worsened by increasing levels of PA. A primary care data
quality analyst from the North of England Commissioning
Support Service will provide each primary care practice
with system specific reports to enable them to identify pa-
tients who meet the eligibility criteria.
Patients registered at each participating practice who
fulfil pre-defined eligibility criteria will be invited to par-
ticipate in the study.
Recruitment procedures
Figure 1 provides an overview of practice and patient
recruitment.
All primary care practices in the County Durham and
Darlington area of North East England will be invited to
participate in the study. The Primary Care Research Net-
work (PCRN) and clinical leads from the North East
Commissioning Service will facilitate practice recruit-
ment by distributing postal invitations to all practices
and making personal contact with practice managers
and clinical commissioning groups.
To allow continuity of care (should one primary
healthcare professional withdraw from the study), a
minimum of two primary healthcare professionals from
each participating practice will be required to provide
informed written consent to take part in the study. Con-
sent will be sought from primary healthcare profes-
sionals to complete the online training intervention
programme and subsequently to deliver the primary
healthcare professional-led intervention to patients re-
cruited to the study (should their practice be randomly
allocated to MaMT2D); and to complete online study
questionnaires at baseline, one, six and twelve months.
Separate consent will be sought to video record consul-
tations with patients for the purposes of treatment fidel-
ity assessment; to take part in one or more interviews
with a researcher to identify barriers and enabling fac-
tors to effective implementation of the intervention in
primary care; and to take part in a focus group discus-
sion with a researcher and other participating primary
healthcare professionals upon completion of the study
(to gauge overall opinion of the intervention and study
processes and procedures, including ways in which they
could be improved). If primary healthcare professionals
decide to opt out of video recordings, interviews and
focus group discussions, they can still participate in the
main study. A member of the research team will obtain
informed written consent from each participating pri-
mary healthcare professional [See Additional file 2:
Healthcare Professional Consent Form and Additional
file 3: Practice Information Sheet]. Two copies of the
Figure 1 Flowchart showing the planned study recruitment processes for primary care practices, professionals and patients.
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copy will be retained by the practice and stored in their
study site file and a second copy retained and filed se-
curely by the research team. The decision regarding par-
ticipation is entirely voluntary and participants are free
to withdraw from the study at any time. Ethicalpermission was not sought to collect data from partici-
pants once they have made a decision to leave the study
(that is, following cessation of outcome data provision
and discontinuation of treatment); although any data
collected up until the point of withdrawal will be in-
cluded in the analyses, unless the participant (health-
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Specific design decisions were made to limit the
amount of missing data in accordance with published
guidance [37]. The MaMT2D intervention was designed
to be flexible and to accommodate individual differences;
therefore, patients will be supported by primary health-
care professionals to identify their activity of choice, in-
cluding frequency, intensity and duration to increase
tolerability. Furthermore, MaMT2D was designed to be
integrated into usual clinical care. Consequently, patients
randomised to the MaMT2D intervention will receive
the intervention components during their usual diabetes
review appointments to reduce burden. Finally, an expe-
rienced research nurse employed by the Diabetes Re-
search Network will collect clinical outcome data from
electronic patient records during each data collection
phase (that is, baseline, one, six and twelve months) to
minimise the burden on participating healthcare profes-
sionals and practice personnel. Information from each
participant consent form will be entered into a password
protected data management system that will record con-
sent preferences (for example, decision to participate or
not in semi-structured interviews). Each practice will be
randomised to the intervention or control group follow-
ing receipt of informed written consent by all participat-
ing primary healthcare professionals.
Practices will be stratified based on list size (with three
cut-off points: <3,280; ≥3,280 to 5,989; ≥5,990 to 10,453;
and >10,454) and randomised to either the intervention
or control group prior to identification and recruitment
of patients.
A nominated member of staff from each participating
practice will be asked to identify all patients registered
on their practice list who meet the eligibility criteria. An
invitation letter printed on practice headed paper, a stan-
dardised patient information sheet and consent form
[See Additional file 4: Patient Information Sheet Control
Group; Additional file 5: Patient Information Sheet Inter-
vention Group; and Additional file 6: Patient Consent
Form] along with a pre-paid envelope will be mailed to
all eligible patients. Patients who do not respond to the
invitation within a six-week period will be mailed a re-
minder letter. Patients will be asked to provide informed
written consent to attend four face-to-face appointments
at their primary care practice; wear an accelerometer for
seven continuous days, complete a study questionnaire
and have clinical measures taken at each data collection
time point (baseline, one, six and twelve months). In
addition, separate consent will be sought to video record
their consultations; to take part in semi-structured inter-
views with a researcher (to identify enabling factors and
barriers to effective implementation of MaMT2D in pri-
mary care); and to take part in a focus group discussionwith a researcher and other participating patients from
their practice upon completion of the study (to gauge
overall opinion of the intervention and study processes
and procedures, including ways in which they could be
improved). If patients decide to opt out of video record-
ings, interviews and focus group discussions, they can
still remain in the main study. Consent from both the
healthcare professional and patient are required before a
video recording of a consultation can take place. The
first two practices to provide informed written consent
will enter the open pilot study described above. Each
practice will be provided with a site file containing a
copy of the trial protocol, patient information sheets and
consent forms for reference purposes and a log for re-
cording and monitoring patient recruitment, attrition
and adverse events. If a drop-out or adverse event occurs,
the contact person at the practice will be asked to contact
a member of the study team to provide details. A log of all
recruitment activity will be maintained by the study team
and stored on a password-protected server at Newcastle
University.
Participating primary healthcare professionals will be
interviewed by a member of the research team prior to,
and following, completion of the online training inter-
vention programme. This training has been accredited
by the Federation of the Royal College of Physicians,
with completion conferring three Continuing Profes-
sional Development points. The online training inter-
vention programme has been designed to: (1) increase
the diabetes and PA related knowledge of primary
healthcare professionals; (2) develop positive attitudes/
beliefs towards use of PA as a management option for
diabetes; (3) enhance self-efficacy for delivering a pri-
mary healthcare professional-led behavioural interven-
tion targeting PA to patients with Type 2 diabetes; and
(4) promote skills development in terms of delivering
specific behaviour change techniques and behaviour
change counselling skills in the context of diabetes
management.
Interviews with primary healthcare professionals will
focus specifically on the acceptability and feasibility of
the MaMT2D intervention, including study processes
and procedures. Suggestions for improvement will be
discussed with the research team and, where feasible, in-
corporated into the intervention, research processes and
procedures for the subsequent pilot randomised con-
trolled trial. Primary healthcare professionals at partici-
pating practices will be asked to review all changes prior
to their implementation. The interview topic guides will
be developed using the Theoretical Domains Framework
(TDF) [38]. The TDF is the result of a multi-disciplinary
expert consensus approach aiming to organise and sim-
plify the theoretical literature on behaviour change by
reviewing 33 behavioural theories and organising the
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commonalities [39]. After further validations, the TDF
consists of 14 theory domains each providing broad ex-
planations of why a behaviour was or was not per-
formed: ‘Knowledge’, ‘Skills’, ‘Professional Role and
Identity’, ‘Beliefs about Capabilities’, ‘Optimism’, ‘Beliefs
about Consequences’, ‘Reinforcement’, ‘Intentions’, ‘Goals’,
‘Memory, Attention and Decision Processes’, ‘Environ-
mental Context and Resources’, ‘Social Influences’, ‘Emo-
tions’ and ‘Behavioural Regulation’ [38]. While the TDF
is not a theory as such, it has been useful in organising
narrative data to link findings of qualitative research back to
theory [40,41] and is used here to identify domain specific
issues with the online training intervention programme (for
example, knowledge/skills gaps) and supporting materials
for the primary healthcare professional-led intervention for
use with patients.
Interviews during phase one will be conducted with
patients immediately following their diabetes review ap-
pointments incorporating MaMT2D at baseline and at
one-month follow-up. Patients will be interviewed by a
member of the research team using a topic guide developed
using the TDF to establish comprehension, acceptability of
the primary healthcare professional-led intervention and to
detect any domain specific issues (for example, information/
support gaps).
Treatment fidelity assessment with primary health-
care professionals (video recordings of MaMT2D con-
sultations with patients) will identify adherence to
components of the primary healthcare professional-led
intervention in accordance with the content of the on-
line training intervention programme. A fidelity check-
list developed for the purpose of this study will be used
to assess presence/absence and appropriate use of inter-
vention components. This will enable insights into po-
tential adaptations or improvements to the online
training intervention programme for primary healthcare
professionals, including the tools (paper-based materials,
DVD and pedometer) used within the primary health-
care professional-led intervention. Review appointments
will be video recorded and assessed for treatment fidelity
only when both participating primary healthcare profes-
sionals and patients provide their informed written con-
sent. Following published guidance, 20% to 40% of
consultations will be video recorded and, where feasible,
equal numbers of consultations will be video recorded at
each intervention time point to ensure representative-
ness of the data set [42].
Healthcare professional and patient data (including
consent, fidelity, outcome data and patient appointment
dates) will be entered in a data management system by a
member of the research team. A data manager from
the Diabetes Research Network will enter patient ques-
tionnaire data at each data collection time point.Questionnaire data from healthcare professionals will be
transferred electronically from Survey Monkey by a
member of the research team. The data management
system will generate alerts via email ahead of each par-
ticipant’s data collection time point and a member of the
research team will respond to these alerts accordingly.
The use of an open pilot study enables an iterative and
systematic approach to intervention adaptation and re-
finement, to optimise the multifaceted intervention for
use in the clinical setting and to refine study processes
and procedures [43].
Amendments to intervention components
An assessment will be made following completion of the
open pilot study to determine whether any amendments
to the intervention and study processes and procedures
are required. All interview data will be analysed by LA
(and a proportion of transcripts analysed by SJD) and
any issues with the intervention, study processes and
procedures will be addressed following discussion with
the research team. A final decision to continue to the
pilot RCT will be made by the principal investigator,
MIT. All video recordings from the open pilot consulta-
tions will be coded by LA (a proportion double coded by
a researcher with expertise in health behaviour change
to ensure reliability) and discussed with the research
team. An assessment will be made as to whether fidelity
of delivery (adherence to intervention components) is
sufficiently high to permit the study to continue to the
pilot RCT in phase two (that is, whether primary health-
care professionals have attained adequate coverage of
intervention components where appropriate). Where
omissions are consistent across primary healthcare pro-
fessionals, reasons for this will be explored and the re-
search team will discuss how the programme can be
improved to increase fidelity during phase two. Measur-
ing adherence to pre-defined intervention components
is quantifiable; however, adherence may not require all
components of an intervention to be delivered during
every individual session [44]. For example, the use of the
technique ‘generalisation of physical activity behaviour’
is unlikely to be used during a baseline session; therefore,
appropriate absence of this technique will be recorded
during the coding process. Where it is appropriate to use
a behaviour change technique or an intervention compo-
nent, a fidelity threshold will be applied where 50% will be
considered ‘sufficiently high’ to continue to the pilot RCT
in phase two.
Following amendments to the intervention, primary
healthcare professionals will be asked to revisit the on-
line training intervention programme and materials to
review any revised (or new) content before continuing to
deliver the intervention to patients. All amendments to
the intervention and study processes and procedures will
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study. Any changes to the study protocol will be
documented.
Movement as Medicine for Type 2 Diabetes: Components
of the intervention
This multifaceted behaviour change intervention com-
prises two distinct but interrelated components: an on-
line training intervention programme for healthcare
professionals and a primary healthcare professional-led
intervention toolkit for patients.
Healthcare professional online training intervention
programme
The online training intervention programme presents
eight distinct but interrelated modules that cover topics
such as diabetes and metabolism, PA and exercise and
the psychology of behaviour change. Module 7 is a dedi-
cated ‘skills based’ module that aims to equip primary
healthcare professionals with the skills to use pre-
selected behaviour change techniques and behaviour
change counselling skills listed previously to promote
patient centeredness and increase PA behaviour in pa-
tients. Textual information, interactive features, video
demonstrations, and consolidation quiz questions at the
end of each core module aim to prepare primary health-
care professionals to confidently and faithfully deliver
the primary healthcare professional-led intervention to
participating patients. Once all content of the training
intervention programme is viewed by primary healthcare
professionals an online certificate will be generated to
confirm completion.
Primary healthcare professionals employed by both
primary care practices will complete the online training
intervention programme component of MaMT2D. They
will be emailed a unique login ID to access the password
protected programme and will be given four weeks to
complete all modules before using the intervention with
patients. Ongoing access to the programme will be pro-
vided for the duration of the study and can be accessed
at any time. Table 1 provides an overview of the
MaMT2D online intervention training programme for
primary healthcare professionals.
Primary healthcare professional-led intervention toolkit
for patients
Patients will, in addition to usual clinical care, receive
the primary healthcare professional-led intervention that
involves support from a trained primary healthcare pro-
fessional to use a range of printed materials, DVD and
pedometer (SW200, Yamax Corporation, Tokyo, Japan)
to help them to increase their everyday levels of PA. The
printed materials comprise: 1) a discussion card present-
ing a decisional balance aid, importance and confidencerulers and a seven-day PA recall diary to enable indivi-
dualised feedback to be provided on current PA behav-
iour (type, frequency, intensity and duration); and (2) a
booklet to support patients through the process of short
and long-term PA goal setting, action planning, self-
monitoring towards their PA goal and encouragement to
use rewards contingent on progress made towards a pre-
viously set PA goal. A menu of PA options is presented
to encourage patient autonomy (that is, to consider what
type of PA they would like to incorporate into their
everyday lives), and activity planners and trackers are
provided to allow patients to self-monitor the amount of
time they spend active (or the number of steps taken
each day) with reference to a predetermined PA goal
(that is, patients will be supported to develop their own
PA goals and plans and revise them based on their indi-
vidual needs and preferences). Table 2 provides an over-
view of the content of the practitioner-led intervention.
Patients will be invited to attend four face-to-face ap-
pointments with a participating primary healthcare pro-
fessional from their practice (baseline, one, six and
twelve months). Where possible, patients will see the
same primary healthcare professional throughout the
duration of the study to provide continuity. During these
appointments they will be given a Diabetes UK leaflet
and will receive the primary healthcare professional-led
intervention. During each appointment the primary
healthcare professional will complete a record of pro-
gress sheet to serve as a log of decisions made during
each appointment (for example, whether a patient se-
lected a preferred activity, set a PA goal and self-
monitoring method). A carbon copy of the progress
sheet will be retained by the primary healthcare profes-
sional to refer to during subsequent appointments. Ma-
terials will be used with all patients during baseline and
one month appointments in both practices before any
necessary changes are made. Once changes are made,
the updated materials will be reintroduced and the study
will continue to the 12-month intervention endpoint.
Follow up prompts have shown promising effects in
behaviour change interventions while targeting a range
of behaviours including physical activity [11,45,46].
Therefore, patients will receive a telephone call three
months from baseline from a primary healthcare profes-
sional to ‘prompt’ PA behaviour. They will be asked if
they have any questions regarding use of the interven-
tion materials and offered support where needed to set
or revise PA goals and receive individualised feedback
based on performance where appropriate. At this time
patients will also receive a ‘motivational’ card by mail
from the research team thanking them for continuing to
take part in the study and encouraging them to consider
ways in which they could reduce their sedentary time
and increase PA behaviour.
Table 1 Components of the online training programme and their relationship to constructs within TPB and SCT
Module Form and information content Theoretical constructs
Module 1: Video recording of a professor of movement
and metabolism introducing the programme
and providing details of how and why MaMT2D
was developed
Symbolising (SCT)
Introduction to MaMT2D Attitudes and beliefs (TPB)
Subjective norms (TPB)
Video recording of a Consultant Diabetologist
and a Diabetes Specialist Nurse providing an
overview of why PA is important for the
management of T2D
Modules 3 (metabolism & type 2 Diabetes),
4 (physical activity in the care of type 2
Diabetes); and 5 (physical activity & exercise)
Evidence-based information about the role of
metabolism, PA and exercise in the context
of Type 2 diabetes
Symbolising (SCT)
Attitudes/beliefs (TPB)
Forethought (SCT)
Intention (TPB)
Module 6: Evidence-based information on the use of
psychological theory and theory linked
behaviour change techniques and counselling
skills to change PA behaviour
Attitudes/beliefs (TPB)
Using psychology to change physical activity
Behaviour
Forethought (SCT)
Intention (TPB)
Module 7: Using behaviour change techniques
to increase physical activity behaviour
Video demonstrations of a Diabetes Specialist
Nurse demonstrating the use of behaviour
change techniques and behaviour change
counselling techniques in practice with a
mock patient
Symbolising (SCT)
Observational Learning (SCT)
Perceived Behavioural Control
(TPB) and Self-efficacy (SCT)
Subjective norms (TPB)
Module 8: Flowchart diagram demonstrating how to
screen adults with T2D prior to PA/exercise
Self-regulation (SCT)
Screening before physical activity Perceived Behavioural Control
(TPB) and Self-efficacy (SCT)
End of module 3,4 and 5 quiz questions Provides feedback on performance Perceived Behavioural Control
(TPB) and Self-efficacy (SCT)
Flowchart summary (crib sheet with prompts)
of the protocol for use of the patient toolkit during
diabetes review appointments
Prompts for healthcare professionals to use
specific behaviour change skills and techniques
Symbolising (SCT)
Perceived Behavioural Control
(TPB) and Self-efficacy (SCT)
Intention (TPB)
Self-regulation (SCT)
MaMT2D, Movement as Medicine for Type 2 Diabetes; TBP, Theory of Planned Behaviour; SCT, Social Cognitive Theory. Module 2 of the online training
intervention programme provided participating healthcare professionals with an overview of the research process, that is how MaMT2D will be evaluated. It was
not designed to target any theoretical constructs and as such was not included in Table 1.
Avery et al. Trials 2014, 15:46 Page 10 of 18
http://www.trialsjournal.com/content/15/1/46Analyses
The focus of phase one (the open pilot study) is accept-
ability and feasibility of the intervention in routine pri-
mary care. Therefore, the proportion of participating
primary healthcare professionals who login to the online
training intervention programme and complete it within
the required time period (four weeks) will be assessed.
The proportion of participating patients who attend/fail
to attend MaMT2D appointments will also be assessed.
Finally, completion rates of questionnaires for both primary
healthcare professionals and patients will be assessed
throughout the open pilot study. Where suggestions for im-
provement are made by primary healthcare professionals
and patients during semi-structured interviews, these will
be discussed by the research team and implemented where
appropriate/feasible. Analyses of these data will be descrip-
tive, with 95% CIs reported where appropriate. Analyses of
qualitative data collected using the Theoretical DomainsFramework will identify domain specific beliefs likely to
positively or negatively influence acceptability and feasibility
of MaMT2D in the primary care setting.
Phase two: Movement as Medicine for Type 2 Diabetes:
Pilot randomised controlled trial
Objectives
The aim is to assess acceptability, feasibility and fide-
lity of MaMT2D in the primary care setting over a
12-month period.
The primary objectives are:
1. To demonstrate that recruitment of primary care
practices and patients to the trial is feasible; to
determine the length of time required to complete
practice and patient recruitment; and to assess
eligibility, recruitment, retention and adherence
rates and willingness to be randomised.
Table 2 Components of the healthcare professional-led intervention and their relationship to constructs within TPB
and SCT
Intervention component Form and information content Theoretical constructs
Discussion card Assessment of PA behaviour using a seven-day recall Attitudes/beliefs (TPB)
Forethought (SCT)
A decisional balance aid to assess the pros versus the cons
for changing PA behaviour
Intention (TPB)
Perceived Behavioural Control (TPB)
and Self-efficacy (TPB)Rulers assessing importance and confidence for change
Booklet Support to select an appropriate PA/exercise; set PA goals;
consider means of social support; identify barriers/problem
solve; set short and long-term goals; plan activity; self-monitor
activity; prevent relapse
Forethought (SCT)
Subjective norms (TPB)
Intention (TPB)
Self-regulation (SCT)
Perceived Behavioural Control (TPB)
and Self-efficacy (TPB)
Activity planners/trackers Means to plan and monitor PA/exercise Self-regulation (SCT)
DVD Video recordings of adults with T2D engaging in PA/exercise
and sharing their stories
Symbolising (SCT)
Attitudes/beliefs (TPB)
Observational Learning (SCT)
Subjective norms (TPB)
Perceived Behavioural Control (TPB)
and Self-efficacy (SCT)
Pedometer Device to monitor the number of steps taken each day Self-regulation (SCT)
Record of progress pad Record of readiness ruler outcomes; short and long-term
PA/exercise goals; social support; potential barriers and ways
to overcome them; self-monitoring method adopted; and
activities of choice. Provides a mechanism for provision of
feedback and an opportunity to monitor progress and recap
during subsequent sessions
Perceived Behavioural Control (TPB)
and Self-efficacy (SCT)
Intention (TPB)
Self-regulation (SCT)
Diabetes UK Leaflet Leaflet entitled: Keeping active: an essential part of
managing diabetes
Attitudes/beliefs (TPB)
Perceived Behavioural Control (TPB)
and Self-efficacy (SCT)
Intention (TPB)
MaMT2D, Movement as Medicine for Type 2 Diabetes; TBP, Theory of Planned Behaviour; SCT, Social Cognitive Theory.
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delivered faithfully and consistently in accordance
with the protocol over a 12-month period.
3. To conduct a qualitative process evaluation to
identify enabling factors and barriers to effective
implementation of MaMT2D in primary care.
The secondary objectives are:
1. To estimate the variability of objectively assessed PA
behaviour, diabetes related knowledge, attitudes/
beliefs, self-efficacy for being physically active and
health related quality of life, HbA1c, blood pressure,
waist circumference and body mass index in patients
by generating interval estimates of the mean differ-
ence between groups for each outcome measure.
2. To estimate the variability both between subjects
and between clusters of PA related knowledge, self-
reported PA behaviour, attitudes/beliefs, self-efficacyfor delivering a behavioural intervention and fidelity
of specific behaviour change techniques and behav-
iour change counselling skills in the context of diabetes
management in primary healthcare professionals. Inter-
val estimates of the mean difference between groups
for each outcome measure will be generated.
Estimates of variability will include the standard devi-
ation, range and interquartile range for each of the study
outcomes. The estimates of standard deviation will be
used to generate 95% CIs for mean scores in each group
and the difference in group means.Methods/Design
The second phase will involve a two-arm parallel group
cluster RCT (practices will be the unit of randomisation)
to assess acceptability, feasibility and fidelity of the inter-
vention and study procedures over a 12-month period.
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A total of 200 patients will be recruited from up to
20 primary care practices in the County Durham and
Darlington area of North East England. The final num-
ber of practices will be identified following completion
of phase one (open pilot) where an assessment of prac-
tice recruitment and retention rates will be conducted,
with reference to practice list size (with three cut-
off points: <3,280; ≥3,280 to 5,989; ≥5,990 to 10,453;
and >10,454); the number of patients fulfilling the eligi-
bility criteria and the number of patients recruited per
practice. Up to 10 practices will be randomised to
MaMT2D and a further 10 to usual clinical care. Al-
though the trial is not powered for a definitive analysis,
exploratory analyses examining between group differ-
ences will be reported based on a calculation of physical
activity behaviour and HbA1c. The data generated from
the pilot RCT including an estimate of the intra-cluster
correlation co-efficient [47] will facilitate a power calcu-
lation to inform a definitive RCT if acceptability, feasibi-
lity and fidelity are demonstrated.
Eligibility criteria for primary care practices and patients
Eligibility criteria for primary healthcare practices and
patients will be identical to those used in phase one.
Recruitment procedures
Figure 1 presented earlier provides an overview of prac-
tice and patient recruitment.
Recruitment procedures will be identical to those used
during the open pilot study and primary healthcare pro-
fessionals from each participating practice will be re-
quired to provide informed written consent prior to
randomisation.
Pilot RCT trial arms
There are two arms to the trial, (1) the control group:
usual clinical care; and (2) the intervention group:
MaMT2D. Despite the known benefits of PA on gly-
caemic control, there remains a lack of evidence-based
interventions designed to increase PA in people with
Type 2 diabetes. Furthermore, it remains unclear what
the optimal strategies are to increase PA behaviour in
people with Type 2 diabetes and whether a programme
such as MaMT2D will be acceptable and feasible in the
primary care setting.
Figure 1 provides an overview of planned recruitment
numbers, timing of the intervention sessions and out-
come measures.
Usual clinical care (control group)
Patients will be asked to attend four face-to-face ap-
pointments (baseline, one, six and twelve months). Dur-
ing the initial appointment they will be given a DiabetesUK leaflet (‘Keeping active: an essential part of managing
diabetes’) [48]. No further information or advice will be
provided to patients about PA over and above usual clin-
ical care.
At the three-month follow-up all participating patients
will receive a telephone call from a primary healthcare
professional at their practice to ask if they have any
questions regarding their diabetes management and par-
ticipation in the study. At the same time patients will be
mailed a postcard by the research team thanking them
for continuing to take part in the study.
Movement as Medicine for Type 2 Diabetes (the
intervention)
Healthcare professional online training intervention
programme
Primary healthcare professionals employed by practices
randomised to the intervention arm of the study will
complete the online training intervention programme
component of MaMT2D (optimised following the open
pilot during phase one). The procedure for access and
content is described previously for the open pilot study.
Primary healthcare practices randomised to deliver
usual clinical care will be offered access to the online
training intervention programme following completion
of the pilot RCT.
Primary healthcare professional-led intervention
Patients will be asked to attend four face-to-face ap-
pointments (baseline, one, six and twelve months). Dur-
ing these appointments they will be given a Diabetes UK
leaflet (also issued to the control group) and will receive the
optimised version of the primary healthcare professional-
led intervention and associated materials informed by
findings of the open pilot in phase one. Intervention
components are described previously for the open pilot
study.
Primary outcome measures
1. An assessment of primary care practices and
patient’s willingness to take part in the trial will be
conducted by examining the proportion of practices
and patients that were both eligible and asked to
participate against those who actually agreed to
participate.
2. The patient identification procedure will be
examined to determine whether identification of
eligible patients from practice lists was feasible, rates
of eligibility and reasons for ineligibility.
3. Acceptability of the study design will be measured
by the number of primary care practices and
patients who take part and remain in the trial (that
is, appointment attendance and intervention, data
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out, where provided will be examined. In a situation
where a patient does not attend an appointment but
contributes data at a specific data collection time
point, this information will be recorded.
4. Primary care practice and patient recruitment rates
will be measured by the number who consent to be
randomised divided by the number eligible to be
randomised and the number taking part in the trial
divided by the length of the recruitment period. The
practice recruitment period begins when the first
round of practice invitations are mailed out and
ends when the last practice recruited is randomised.
Patient recruitment begins when the first group of
eligible patients is mailed their invitation letter and
ends when the last patient recruited provides
informed written consent.
5. Willingness to take part in video recordings of
consultations, semi-structured interviews and focus
group discussions will be assessed in both the inter-
vention and control groups.
6. Adherence to the study protocol (fidelity
assessment) and barriers/facilitators to effective
implementation of MaMT2D in the primary care
setting will be assessed throughout the trial period.
A proportion of consultations will be video recorded
to assess adherence to intervention components; and
data collection completion rates will be monitored
and recorded at each data collection time point.
Semi-structured interviews with participating pri-
mary healthcare professionals and patients will be
conducted to identify barriers and enabling factors
to implementation of the intervention in routine pri-
mary care.
Secondary outcome measures
1. Estimates of variability will be calculated for
objectively assessed PA behaviour and diabetes-
related knowledge, attitudes/beliefs, self-efficacy for
being physically active, health related quality of life,
HbA1c, blood pressure, waist circumference and
body mass index in patients at each data collection
time point. Estimates of variability will include the
standard deviation, range and interquartile range for
each study outcome. Estimates of standard deviation
will be based on an appropriate multilevel model
(subjects nested within practices); the variance will
be partitioned into between subject and between
practice components.
2. Estimates of variability will be calculated for fidelity
of specific behaviour change techniques, behaviour
change counselling skills (in the context of diabetes
management) and PA related knowledge, self-reported PA behaviour, attitudes/beliefs and self-
efficacy for delivering a behavioural intervention.
3. A qualitative process evaluation will be undertaken
concurrently to assess barriers and facilitators to
effective implementation of the intervention into
routine primary care. A refined and optimised
version of both components of MaMT2D (online
training intervention programme for primary
healthcare professionals and the range of printed
materials, DVD and pedometer (SW200, Yamax
Corporation, Tokyo, Japan) for patients (as part of
the primary healthcare professional-led intervention)
will be compared with usual clinical care. Assess-
ment of all outcomes will inform future work (for
example, a definitive RCT).
Patient outcome measures
PA behaviour will be measured objectively using a
blinded (that is, no data visible to patients) wrist worn
tri-axial accelerometer (GENEActiv, ActivInsights Ltd,
Kimbolton, UK) for seven continuous days at each data
collection time point. Clinical outcome measures, com-
prising glycaemic control (HbA1c), diastolic and systolic
blood pressure (mmHg), waist circumference (cm) and
body mass index (kg/m2), will be measured and recorded
by primary healthcare professionals during review ap-
pointments. Self-reported PA (International Physical Ac-
tivity Questionnaire (IPAQ)) [49]; diabetes-related
knowledge (Audit of Diabetes Knowledge (ADKnowl))
[50]; behavioural intentions, subjective norms and atti-
tudes/beliefs about PA for the management of diabetes
(Physical Activity Questionnaire for Diabetic Patients
(PAQ-DP)) [51]; PA-related self-efficacy [52]; and
health-related quality of life (Audit of Diabetes
Dependent Quality of Life (ADDQoL)) [53] will be mea-
sured by self-report postal questionnaire. Each outcome
will be assessed at baseline, one, six and twelve-month
follow up. Background information will be collected
from patients on age, gender, employment status, length
of time since diagnosis of Type 2 diabetes and method
of diabetes control (that is, diet, oral medication).
Healthcare professional outcome measures
Change in consultation behaviour involving utilisation of
selected behaviour change techniques and behaviour
change counselling techniques will be assessed subject-
ively using a questionnaire specifically developed for the
purpose of this study. Objective assessments will be
made by video recording a sub-sample of primary
healthcare professionals in practice. Self-reported dia-
betes and PA-related knowledge; behavioural intentions,
subjective norms, attitudes/beliefs about PA as a man-
agement option for Type 2 diabetes (adapted PAQ-DP)
[51]; self-efficacy for delivering a behaviour change
Avery et al. Trials 2014, 15:46 Page 14 of 18
http://www.trialsjournal.com/content/15/1/46intervention [52]; and PA behaviour (IPAQ) [49] will be
assessed by online questionnaire at each data collection
time point (baseline, one, six and twelve months follow
up). Background information will be collected about
current job title and role, length of time in current role,
details of any previous training undertaken in the area of
health behaviour change (for example, behaviour change
counselling and motivational interviewing), diabetes and
PA for the management of Type 2 diabetes.
Treatment fidelity assessment
A sub-sample (20% to 40%) of consultations will be
video recorded to assess fidelity of primary healthcare
professionals use of specific behaviour change tech-
niques and behaviour change counselling techniques
within MaMT2D consultations (and usual care consulta-
tions) with patients. Each intervention component will
be coded as either ‘present’ or ‘absent ‘and an assess-
ment will be made on the extent to which it was utilised
(that is, how closely delivery meets pre-specified criteria
of behaviour change techniques (BCTs) and intervention
components). The Behaviour Change Counselling Index
(BECCI) [54] will be used to assess primary healthcare
professional’s use of behaviour change counselling skills
to enhance patient-centeredness of consultations. A sub-
sample of video recordings will be double coded by a
second coder and any discrepancies will be resolved by a
third coder. All coders will have expertise in theory-
linked BCTs, including experience using the 40-item
taxonomy [55] used to define BCTs and behaviour
change counselling techniques included in MaMT2D.
This assessment will enable quantification of primary
healthcare professional and patient interactions, to pro-
vide insights into the therapeutic relationship, as well as
allow an assessment to be made as to whether this rela-
tionship translates into actual PA behaviour change. The
outcome of these analyses obtained during the pilot
RCT will help to understand the nature of the inter-
action during MaMT2D consultations and usual clinical
care, and to identify any potential barriers and facilita-
tors to effective implementation of the intervention in
routine primary care. Assessment of treatment fidelity
will help determine whether any estimated differences
detected in objectively assessed PA behaviour between
the intervention and control group patients can be at-
tributed to any changes in consultation behaviour of par-
ticipating primary healthcare professionals (influenced
by the online training intervention programme) [42,56].
To maximise treatment fidelity a number of strategies
will be used.
Treatment fidelity strategies for design of the study
Both intervention and control group patients will receive
the same ‘treatment dose’ (that is, the same number ofcontacts from primary healthcare professionals and the
research team). To plan for implementation setbacks a
minimum of two primary healthcare professionals will
be recruited (and trained in the intervention arm of the
study) from each primary care practice. By utilising
treatment fidelity strategies related to study design, the
study aims and objectives can be adequately tested.
Treatment fidelity strategies for monitoring and
improving provider training
A standardised online training intervention programme
will be provided to ensure all primary healthcare profes-
sionals in the intervention arm of the study receive ac-
cess to the same training content. Where primary
healthcare professionals do not adhere sufficiently to de-
livery of pre-selected behaviour change techniques and
behaviour change counselling skills, the research team
will explore possible reasons for this and changes to the
intervention will be made as appropriate during the
open pilot study. Video recordings of consultations will
be made throughout phases one and two to assess skill
acquisition, utilisation and treatment fidelity.
Treatment fidelity strategies for monitoring and
improving receipt of the intervention
A qualitative process evaluation and treatment fidelity
assessment will be conducted throughout phases one
and two to assess primary healthcare professional per-
formance on delivery of specific behaviour change tech-
niques and behaviour change counselling skills.
Qualitative process evaluation
Interviews will be carried out with a purposive sample of
primary healthcare professionals and patients during
phases one and two of the study. Interview topic guides
will be developed using the TDF [38]. The outcome of
interviews will help to optimise the intervention, and
streamline study processes and procedures during phase
one and to obtain an in-depth understanding of barriers
and facilitators to successful implementation during
phase two. Interviews will be audio recorded, transcribed
and data will be analysed using thematic analysis. A pro-
portion of transcripts will be analysed by a second
researcher.
Data collection, storage and security
Data collected via audio recorders, video recorders and
accelerometers will be saved to a password protected
server in the Institute of Cellular Medicine (ICM) at
Newcastle University. These data will be accessed only
by members of the research team. Once all data have
been uploaded to the server they will be securely deleted
from the recording devices. Patient questionnaire data
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in the ICM.
Randomisation and concealment of allocation
Practice recruitment will be carried out in two stages.
Practices will be randomly allocated to the intervention
or usual clinical care group after each recruitment stage
and following receipt of informed written consent from
participating primary healthcare professionals. Consent
will be obtained by a member of the research team who
is blind to details of randomisation sequencing and con-
cealment. Practices will be allocated to one of four strata
based on list size with three cut-off points: <3,280;
≥3,280 to 5,989; ≥5,990 to 10,453; and >10454 (thresh-
olds based on quartiles of distribution of list size across
all practices in the County Durham & Darlington area of
North East England) and will be randomised independ-
ently within strata using random permuted blocks. The
blocks will be generated using a subroutine that utilises
the ‘rand()’ function built into the programming lan-
guage awk implemented on the central Linux system at
Newcastle University. The size of blocks will be con-
cealed until the end of recruitment.
Blinding
It is inherently difficult to blind primary healthcare pro-
fessionals and patients in behavioural interventions with
the nature of usual clinical care for diabetes being so
well defined. Therefore, blinding of participants will not
be possible. Due to pragmatic reasons researchers will
not be blinded to group allocation of participating prac-
tices; however, the statistical analyses will be performed
by a statistician blind to the treatment allocation of par-
ticipating primary healthcare professionals and patients.
Analyses
Analyses of data collected from phase two (the pilot
RCT) will be descriptive with key outcomes being inter-
val estimates of the variables of interest relating to
assessment of acceptability, feasibility and data com-
pleteness. Although we may not have the power to
detect a clinically important difference between groups
we will generate interval estimates of the mean differ-
ence between groups for the main outcome measures to
be included in a definitive trial (for example, PA and
HbA1c). This will allow us to test the appropriateness of
our analytic procedures. As this is a pilot study, the level
of missing data will be documented but no imputation
will be undertaken. Since we can not rule out the possi-
bility of a very large difference between groups, the out-
come of the analyses may suggest that a larger trial is
not required. Planned exploratory sub-group analyses
will be conducted to determine whether differences exist
between primary healthcare professionals based on roleand between patients as a function of gender, age,
method of diabetes control and length of time since
diagnosis of Type 2 diabetes.
Ethical Approval
A favourable ethical opinion for this study (protocol ver-
sion 1.1) was granted by Sunderland Research Ethics
Committee (application number 12/NE/0037). National
Health Service (NHS) Research & Development approval
was granted by NHS County Durham & Darlington. The
trial was subsequently adopted by the CLRN portfolio to
receive support from both the Diabetes Research Net-
work (DRN) and Primary Care Research Network
(PCRN).
Discussion
PA/exercise is an integral part of diabetes management.
However, the use of PA/exercise in routine clinical care
for adults with Type 2 diabetes is hindered by the lack of
acceptable, feasible and robustly evaluated interventions.
Availability of such interventions will enable diabetes
care providers to support their patients to increase and
maintain their levels of free-living PA that are sufficient
for achieving long-term glycaemic control.
The effective delivery of behavioural interventions is
compromised by the lack of evidence-based training pro-
grammes to equip healthcare professionals with a range
of intervention-specific competencies (knowledge and
skills) and confidence to support adults with Type 2 dia-
betes to become more physically active in the long-term.
A systematic review of 17 trials reported use of treat-
ment fidelity measures in a majority of studies in terms
of study design (for example, consistent duration and
frequency of sessions across trial arms) and monitoring
to improve receipt of intervention components and en-
actment of intervention–related knowledge and skills by
patients [11]. In contrast, treatment fidelity strategies to
monitor and improve provider training and delivery of
treatment in practice were frequently omitted (for ex-
ample, use of standardised training materials, observa-
tion of intervention implementation during training and
video recordings of sessions with intervention providers
and recipients). Training of intervention providers and
treatment fidelity assessment are important for ensuring
reproducibility of intervention-related skills in clinical
practice and increasing the likelihood of implementation
in routine clinical care [43,56].
The current study aims to address the above three bar-
riers to facilitate use of PA as a management option for
Type 2 diabetes in the routine primary care setting.
MaMT2D is, to the best of our knowledge, the UK’s first
online accredited training intervention programme to
support primary healthcare professionals to develop the
competencies to effectively deliver a primary healthcare
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maintenance of free-living PA in patients with Type 2
diabetes.
MaMT2D has been developed through a structured
participatory design process, involving healthcare profes-
sionals and adults with Type 2 diabetes in the primary
care setting working alongside psychologists, physiolo-
gists, designers and clinical experts. The theoretical
underpinning of the multifaceted behaviour change
intervention is evidence-based and the content informed
by a systematic review of the evidence on behaviour
change strategies and other intervention features used in
behavioural interventions targeting free-living PA in
adults with Type 2 diabetes. The approach used to de-
velop the intervention maximises the likelihood that
MaMT2D is acceptable and feasible for use by primary
healthcare providers and patients in the clinical setting.
An open pilot design will allow opportunities for opti-
misation and refinement of study procedures and infor-
mation content of both the online training intervention
(primary healthcare professionals) and paper-based ma-
terials in the patient toolkit for use within the primary
healthcare professional-led intervention in accordance
with the preferences of primary healthcare professionals
and patients. A subsequent external pilot cluster RCT
(informed by the findings of the open pilot) and con-
comitant qualitative process evaluation and fidelity as-
sessment will assess to what extent intervention
components can be reliably and faithfully delivered in
routine practice. Interval estimates of the mean differ-
ence between groups for the main outcome measures at
each time point will be reported. Treatment fidelity
strategies (use of standardised training, study manuals,
ongoing process evaluation and video recording and as-
sessment of patient sessions (intervention and usual
clinical care)) will be utilised throughout the interven-
tion period to serve two main purposes: 1) to ensure the
intervention is being delivered according to the protocol;
and 2) to identify any barriers to successful delivery of
the intervention content and implementation in routine
practice.
Trial status
Recruitment of primary healthcare practices to MaMT2D
commenced during July 2012. At the time of manuscript
submission, twelve practices had provided informed
written consent to participate and eleven had been
randomised.
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